Skip to main content
SpringerLink
Log in
Book cover

Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract pp 221–236Cite as

Clinical Approaches of Emergencies in Neuroendocrine Tumors

  • Chapter
  • First Online:

  • 1340 Accesses

Abstract

Neuroendocrine tumors (NET) are a rare and heterogeneous group of tumors that represent a wide variety of clinical problems leading to many challenges for the clinician, including several emergencies. In this chapter, we will detail on selection of relevant emergencies that occur as complications of NETs. We will focus on the following topics: carcinoid syndrome, carcinoid crisis, and preoperative, intraoperative, and postoperative management to prevent a carcinoid crisis, carcinoid heart disease, approach of MEN-1, insulinoma, and VIPoma, and at least the challenge of a pheochromocytoma.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Melnyk DL (1997) Update on carcinoid syndrome. AANA J 65(3):265–270

    CAS  PubMed  Google Scholar 

  2. Kulke MH, Mayer RJ (1999) Carcinoid tumors. N Engl J Med 340(11):858–868

    Article  CAS  PubMed  Google Scholar 

  3. Modlin IM, Sandor A (1997) An analysis of 8,305 cases of carcinoid tumors. Cancer 79(4):813–829

    Article  CAS  PubMed  Google Scholar 

  4. Van der Lely AJ, de Herder WW (2005) Carcinoid syndrome: diagnosis and medical management. Arq Bras Endocrinol Metabol 49(5):850–860

    Article  PubMed  Google Scholar 

  5. Vaughan DJ, Brunner MD (1997) Anesthesia for patients with carcinoid syndrome. Int Anesthesiol Clin 35(4):129–142

    Article  CAS  PubMed  Google Scholar 

  6. Mancuso K, Kaye AD, Boudreaux JP et al (2011) Carcinoid syndrome and perioperative anesthetic considerations. J Clin Anesth 23(4):329–341

    Article  PubMed  Google Scholar 

  7. Appetecchia M, Baldelli R (2010) Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives. J Exp Clin Cancer Res 29:19

    Article  PubMed Central  PubMed  Google Scholar 

  8. Ramage JK, Ahmed A, Ardill J et al (2012) Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut 61(1):6–32

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Kahil ME, Brown H, Fred HL (1964) The carcinoid crisis. Arch Intern Med 114:26–28

    Article  CAS  PubMed  Google Scholar 

  10. Kinney MA, Warner ME, Nagorney DM et al (2001) Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours. Br J Anaesth 87(3):447–452

    Article  CAS  PubMed  Google Scholar 

  11. Furse RM, Green CJ, Mee AS (2008) Carcinoid syndrome unmasked by fluoxetine, a selective serotonin reuptake inhibitor. Clin Gastroenterol Hepatol 6(8):e27–e28

    Article  PubMed  Google Scholar 

  12. Claure RE, Drover DD, Haddow GR, Esquivel CO, Angst MS (2000) Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anesthetic management. Can J Anaesth 47(4):334–337

    Article  CAS  PubMed  Google Scholar 

  13. Camilleri M, Bueno L, de Ponti F, Fioramonti J, Lydiard RB, Tack J (2006) Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders. Gastroenterology 130(5):1421–1434

    Article  CAS  PubMed  Google Scholar 

  14. Beattie DT, Smith JA (2008) Serotonin pharmacology in the gastrointestinal tract: a review. Naunyn Schmiedebergs Arch Pharmacol 377(3):181–203

    Article  CAS  PubMed  Google Scholar 

  15. Pavel M, Baudin E, Couvelard A et al (2012) ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 95(2):157–176

    Article  CAS  PubMed  Google Scholar 

  16. De Herder WW, Lamberts SW (2002) Somatostatin and somatostatin analogues: diagnostic and therapeutic uses. Curr Opin Oncol 14(1):53–57

    Article  PubMed  Google Scholar 

  17. Bauer W, Briner U, Doepfner W et al (1982) SMS 201–995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31(11):1133–1140

    Article  CAS  PubMed  Google Scholar 

  18. Gupta S, Engstrom PF, Cohen SJ (2011) Emerging therapies for advanced gastroenteropancreatic neuroendocrine tumors. Clin Colorectal Cancer 10(4):298–309

    Article  PubMed  Google Scholar 

  19. Roy RC, Carter RF, Wright PD (1987) Somatostatin, anaesthesia, and the carcinoid syndrome. Peri-operative administration of a somatostatin analogue to suppress carcinoid tumour activity. Anaesthesia 42(6):627–632

    Article  CAS  PubMed  Google Scholar 

  20. Caplin ME, Buscombe JR, Hilson AJ, Jones AL, Watkinson AF, Burroughs AK (1998) Carcinoid tumour. Lancet 352(9130):799–805

    Article  CAS  PubMed  Google Scholar 

  21. Rinke A, Müller HH, Schade-Brittinger C et al (2009) Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 27(28):4656–4663

    Article  CAS  PubMed  Google Scholar 

  22. Öberg KE (2010) Gastrointestinal neuroendocrine tumors. Ann Oncol 21(Suppl 7):vii72–vii80

    PubMed  Google Scholar 

  23. Salazar R, Wiedenmann B, Rindi G, Ruszniewski P (2012) ENETS 2011 consensus guidelines for the management of patients with digestive neuroendocrine tumors: an update. Neuroendocrinology 95(2):71–73

    Article  CAS  PubMed  Google Scholar 

  24. Wymenga AN, de Vries EG, Leijsma MK, Kema IP, Kleibeuker JH (1998) Effects of ondansetron on gastrointestinal symptoms in carcinoid syndrome. Eur J Cancer 34(8):1293–1294

    Article  CAS  PubMed  Google Scholar 

  25. Westergaard H (2007) Bile Acid malabsorption. Curr Treat Options Gastroenterol 10(1):28–33

    PubMed  Google Scholar 

  26. Pratila MG, Pratilas V (1991) Propofol infusion in carcinoid syndrome. Can J Anaesth 38(7):943–944

    Article  CAS  PubMed  Google Scholar 

  27. Harris CE, Murray AM, Anderson JM, Grounds RM, Morgan M (1988) Effects of thiopentone, etomidate and propofol on the haemodynamic response to tracheal intubation. Anaesthesia 43(Suppl):32–36

    Article  PubMed  Google Scholar 

  28. Naguib M, Magboul MM (1998) Adverse effects of neuromuscular blockers and their antagonists. Middle East J Anesthesiol 14(5):341–373

    CAS  PubMed  Google Scholar 

  29. Pellikka PA, Tajik AJ, Khandheria BK et al (1993) Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation 87(4):1188–1196

    Article  CAS  PubMed  Google Scholar 

  30. Zuetenhorst JM, Taal BG (2003) Carcinoid heart disease. N Engl J Med 348(23):2359–2361 author reply 2359–2361

    Article  PubMed  Google Scholar 

  31. Lundin L (1991) Carcinoid heart disease. A cardiologist’s viewpoint. Acta Oncol 30(4):499–502

    Article  CAS  PubMed  Google Scholar 

  32. Lundin L, Norheim I, Landelius J, Oberg K, Theodorsson-Norheim E (1988) Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation 77(2):264–269

    Article  CAS  PubMed  Google Scholar 

  33. Dumoulein M, Verslype C, Van Cutsem E et al (2010) Carcinoid heart disease: case and literature review. Acta Cardiol 65(2):261–264

    Article  PubMed  Google Scholar 

  34. Dero I, De Pauw M, Borbath I et al (2009) Carcinoid heart disease: a hidden complication of neuroendocrine tumours. Acta Gastroenterol Belg 72(1):34–38

    CAS  PubMed  Google Scholar 

  35. Zuetenhorst JM, Bonfrer JM, Korse CM, Bakker R, Van Tinteren H, Taal BG (2003) Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor. Cancer 97(7):1609–1615

    Article  CAS  PubMed  Google Scholar 

  36. Piecha G, Chudek J, Więcek A (2010) Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Int J Endocrinol 2010:928383

    Article  PubMed Central  PubMed  Google Scholar 

  37. Milan SA, Yeo CJ (2012) Neuroendocrine tumors of the pancreas. Curr Opin Oncol 24(1):46–55

    Article  PubMed  Google Scholar 

  38. Whipple AO, Frantz VK (1935) Adenoma of islets cells with hyperinsulinism: a review. Ann Surg 101(6):1299–1335

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Jensen RT, Cadiot G, Brandi ML et al (2012) ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology 95(2):98–119

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  40. Service FJ (1995) Hypoglycemic disorders. N Engl J Med 332(17):1144–1152

    Article  CAS  PubMed  Google Scholar 

  41. Lairmore TC, Moley JF (2004) Endocrine pancreatic tumors. Scand J Surg 93(4):311–315

    CAS  PubMed  Google Scholar 

  42. Tutt GO, Edis AJ, Service FJ, van Heerden JA (1980) Plasma glucose monitoring during operation for insulinoma: a critical reappraisal. Surgery 88(3):351–356

    Google Scholar 

  43. Chen H, Sippel RS, O’Dorisio MS et al (2010) The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 39(6):775–783

    Article  PubMed Central  PubMed  Google Scholar 

  44. Pacak K (2007) Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab 92(11):4069–4079

    Article  CAS  PubMed  Google Scholar 

  45. Kantorovich V, Eisenhofer G, Pacak K (2008) Pheochromocytoma: an endocrine stress mimicking disorder. Ann N Y Acad Sci 1148:462–468

    Article  PubMed Central  PubMed  Google Scholar 

  46. Baumann BM, Cline DM, Pimenta E (2011) Treatment of hypertension in the emergency department. J Am Soc Hypertens 5(5):366–377

    Article  PubMed  Google Scholar 

  47. Chang BB, Phan AT, Yao JC (2006) Neuroendocrine carcinoma. In: Wolff RA, Koller CA, Katarjian HM (eds) The M.D. Anderson manual of medical oncology. McGraw-Hill, New York, pp 449–460

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Digestive Oncology, University Hospitals Leuven and KU Leuven, Leuven, Belgium

    Geertrui Mertens, Saskia Carton & Eric Van Cutsem

  2. Digestive Oncology and Hepatology, University Hospitals Leuven and KU Leuven, Leuven, Belgium

    Chris Verslype

Authors
  1. Geertrui Mertens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saskia Carton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chris Verslype
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eric Van Cutsem
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eric Van Cutsem .

Editor information

Editors and Affiliations

  1. Medical Oncology, Bichat-Beaujon University Hospitals, Clichy cedex, France

    Eric Raymond

  2. Bichat-Beaujon University Hospitals Medical Oncology, Clichy cedex, France

    Sandrine Faivre

  3. Pancreatology, Bichat-Beaujon University Hospitals Gastroenterology and, Clichy cedex, France

    Philippe Ruszniewski

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag France

About this chapter

Cite this chapter

Mertens, G., Carton, S., Verslype, C., Van Cutsem, E. (2014). Clinical Approaches of Emergencies in Neuroendocrine Tumors. In: Raymond, E., Faivre, S., Ruszniewski, P. (eds) Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract. Springer, Paris. https://doi.org/10.1007/978-2-8178-0430-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0430-9_15

  • Published:

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0429-3

  • Online ISBN: 978-2-8178-0430-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation